< Radiation Oncology < Uterine Sarcoma


Uterine Sarcoma Overview


  • Comprise <1% of GYN malignancies and 2-5% of uterine malignancies
  • Three distinct tissues of origin:
    • Carcinosarcoma (mixed mullerian tumor): endometrium, accounts for 40-50%. High frequency of TP53 mutations.
      • Subtypes:
        • Heterologous type:
          • Sarcomatous components derived from skeletal muscle, cartilage, or bone; frequently rhabdomyosarcomas or chondrosarcomas
          • More aggressive, poorer prognosis, higher risk of recurrence
        • Homologous type: Sarcomatous component derived from endometrium, usually resemble high-grade undifferentiated sarcoma or fibrosarcoma
      • GOG 150: Whole Abdominal Irradiation (WAI) vs Cisplatin-Ifosfamide and Mesna (CIM) as post-surgical therapy
      • 206 patients with uterine carcinosarcoma
        • Stages I-IV eligible as long as no demonstrable parenchymal hepatic involvement or extra-abdominal distant disease
        • All patients underwent TAH, BSO, and maximal resection of all gross intra-abdominal/pelvic disease, including macroscopically involved pelvic and para-aortic nodes, leaving no residual disease any larger than 1 cm
        • WAI: 1 cm margins on the diaphragm superiorly, the inguinal ligament inferiorly, and the lateral aspect of the peritoneal margin laterally; AP/PA; total dose 30 Gy. 20 Gy 4-field boost to true pelvis.
        • CIM: cisplatin (20 mg/m2/day IV × 4 days) that was to be followed by a one hour IV administration of Ifosfamide (1.5 g/m2/day IV × 4 days) with mesna (120 mg/m2 IV bolus over 15 minutes on day one, followed by 1.5 g/m2/day IV continuous infusion × 4 days beginning with day one) every three weeks for three cycles.
        • Primary endpoints: Death and recurrence rates
          • No statistically significant difference in time to recurrence (at 5 years, 58% WAI vs 52% CIM)
          • No statistically significant difference in survival time (at 5 years, 35% WAI vs 45% CIM)
          • Slightly more vaginal recurrences in CIM group and more abdominal recurrences in WAI group, but not statistically significant
        • AEs: Higher grade 3 or 4 acute anemia and neuropathy in CIM group, higher grade 2-4 gastrointestinal events in WAI group. Two WAI patients died of radiation hepatitis. One CIM patient died of acute port infection complicated by neutropenia.
This article is issued from Wikibooks. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.